ACL vs BMT

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

ACL

AUCLINICAL FPO [ACL]

44LOW

BMT

BEAMTREEHD FPO [BMT]

44LOW

Score Breakdown

ACL BMT
Technical
65
78
Catalyst
51
61
Sentiment
50
50
Fundamental
73
78
Momentum
41
42
Risk Gate
36
50

Key Metrics

ACL Metric BMT
$383.3MMarket Cap$42.1M
615KAvg Volume (20d)1.7M
+5.7%Short InterestN/A
$3.24052-Week High$0.325
$1.94052-Week Low$0.130
+1.0%Daily Change+3.6%
$2.040Entry Price$0.145
+16.7%ROE-13.8%
+3.6%Profit Margin-20.0%

Active Signals

ACL Signals

RSI drifting toward oversold territory — worth watching
MACD momentum is picking up steam
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.5x)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
Near 52-week low (6% of range)

BMT Signals

RSI drifting toward oversold territory — worth watching
MACD just crossed bullish — momentum is shifting to the upside
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare ACL and BMT in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ACL Full Analysis → BMT Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).